review article | Q7318358 |
scholarly article | Q13442814 |
P50 | author | Claire Wainwright | Q18162529 |
Helen K Reddel | Q41616561 | ||
P2093 | author name string | Darryl A Knight | |
Michiaki Mishima | |||
T K Lim | |||
P2860 | cites work | A bench test to confirm the core features of volume-assured non-invasive ventilation | Q46831731 |
Comorbidity and mortality in COPD-related hospitalizations in the United States, 1979 to 2001. | Q47707059 | ||
Induction of epithelial-mesenchymal transition in primary airway epithelial cells from patients with asthma by transforming growth factor-beta1. | Q47906103 | ||
Neurotrophins are increased in bronchoalveolar lavage fluid after segmental allergen provocation | Q48332226 | ||
Long-term non-invasive ventilation to manage persistent ventilatory failure after COPD exacerbation. | Q48354169 | ||
Nocturnal non-invasive nasal ventilation in stable hypercapnic COPD: a randomised controlled trial. | Q48409630 | ||
Relationship between cystic fibrosis respiratory tract bacterial communities and age, genotype, antibiotics and Pseudomonas aeruginosa. | Q50561588 | ||
The effect of chronic infection with Aspergillus fumigatus on lung function and hospitalization in patients with cystic fibrosis. | Q51134002 | ||
Measurement of exhaled nitric oxide: comparison of different analysers. | Q51539111 | ||
Gender differences in transcriptional regulation of IL-5 expression by bronchial lymph node cells in a mouse model of asthma. | Q51575351 | ||
Peak power estimated from 6-minute walk distance in Asian patients with idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease. | Q51703026 | ||
Noninvasive ventilation in chronic respiratory failure: effects on quality of life. | Q51848816 | ||
Volume-monitored chest CT: a simplified method for obtaining motion-free images near full inspiratory and end expiratory lung volumes. | Q53292819 | ||
Stenotrophomonas maltophilia in cystic fibrosis: serologic response and effect on lung disease. | Q53297625 | ||
Allergy is an important factor in asthma exacerbation: A Pro/Con Debate | Q57137744 | ||
Midregional Proatrial Natriuretic Peptide Predicts Survival in Exacerbations of COPD | Q57759246 | ||
Chronic Obstructive Pulmonary Disease Biomarker(s) for Disease Activity Needed—Urgently | Q57955794 | ||
Systemic corticosteroid and reactivation of chronic hepatitis B | Q58235856 | ||
Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutation | Q24624885 | ||
Dynamics of Pseudomonas aeruginosa genome evolution | Q24652525 | ||
A large-scale, consortium-based genomewide association study of asthma | Q28293885 | ||
Cough challenge in the assessment of cough reflex | Q28362540 | ||
Genome-wide association study identifies BICD1 as a susceptibility gene for emphysema | Q29416999 | ||
Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix | Q29619797 | ||
Efficacy of a cell phone-based exercise programme for COPD. | Q30369636 | ||
Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program | Q30433207 | ||
Randomized trial of the effect of drug presentation on asthma outcomes: the American Lung Association Asthma Clinical Research Centers | Q33487035 | ||
Polymorphisms in the transforming growth factor-beta1 gene and the risk of asthma: A meta-analysis | Q33561200 | ||
Genome-wide association study of asthma identifies RAD50-IL13 and HLA-DR/DQ regions | Q33669033 | ||
Variants in FAM13A are associated with chronic obstructive pulmonary disease | Q33687879 | ||
Failure to recover to baseline pulmonary function after cystic fibrosis pulmonary exacerbation | Q33744911 | ||
Macrophages: regulators of sex differences in asthma? | Q33868557 | ||
Infectious etiology of acute exacerbations of chronic bronchitis | Q33937735 | ||
Basement membrane and vascular remodelling in smokers and chronic obstructive pulmonary disease: a cross-sectional study. | Q34053645 | ||
Short-term associations between ambient air pollutants and pediatric asthma emergency department visits | Q34065616 | ||
Variants of DENND1B associated with asthma in children | Q34089817 | ||
The safety of long-acting beta-agonists: more evidence is needed | Q34125622 | ||
Dynamics of tidal volume and ventilation heterogeneity under pressure-controlled ventilation during bronchoconstriction: a simulation study | Q34236396 | ||
Emergence of Pseudomonas aeruginosa strains producing high levels of persister cells in patients with cystic fibrosis | Q34309282 | ||
A sequence variant on 17q21 is associated with age at onset and severity of asthma | Q34329425 | ||
Step-up therapy for children with uncontrolled asthma receiving inhaled corticosteroids | Q34341203 | ||
The Tennessee Children's Respiratory Initiative: Objectives, design and recruitment results of a prospective cohort study investigating infant viral respiratory illness and the development of asthma and allergic diseases | Q34356477 | ||
The accessory genome of Pseudomonas aeruginosa | Q34431840 | ||
Rhinovirus C and respiratory exacerbations in children with cystic fibrosis | Q34907979 | ||
Multicenter evaluation of infant lung function tests as cystic fibrosis clinical trial endpoints | Q35173510 | ||
Effectiveness and safety of bronchial thermoplasty in the treatment of severe asthma: a multicenter, randomized, double-blind, sham-controlled clinical trial | Q35716134 | ||
Lung function decline in asthma: association with inhaled corticosteroids, smoking and sex | Q36183912 | ||
A genome-wide association study on African-ancestry populations for asthma | Q36709708 | ||
Are there reasons why adult asthma is more common in females? | Q36793287 | ||
The DeltaF508-CFTR mutation results in increased biofilm formation by Pseudomonas aeruginosa by increasing iron availability. | Q36808070 | ||
Systemic inflammation and mortality in chronic obstructive pulmonary disease | Q36814780 | ||
Overdiagnosis of asthma in obese and nonobese adults | Q36972439 | ||
Eosinopenia of acute infection: Production of eosinopenia by chemotactic factors of acute inflammation | Q37023003 | ||
A new perspective on concepts of asthma severity and control. | Q37256164 | ||
An 18‐month study of the safety and efficacy of repeated courses of inhaled aztreonam lysine in cystic fibrosis | Q37403066 | ||
Should FEV1/FEV6 replace FEV1/FVC ratio to detect airway obstruction? A metaanalysis | Q37435290 | ||
Analysis of acquisition of Pseudomonas aeruginosa gastrointestinal mucosal colonization and horizontal transmission in a murine model. | Q37468187 | ||
An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice | Q37522916 | ||
Fractional exhaled nitric oxide in asthma: an update | Q37598970 | ||
Eosinopenia as a marker of mortality and length of stay in patients admitted with exacerbations of chronic obstructive pulmonary disease | Q37641399 | ||
Home-based pulmonary rehabilitation in chronic obstructive pulmonary disease patients | Q37682057 | ||
Asthma: time to confront some inconvenient truths. | Q37701957 | ||
Targeting abnormal airway vascularity as a therapeutical strategy in asthma | Q37718955 | ||
Does the current stepwise approach to asthma pharmacotherapy encourage over-treatment? | Q37729357 | ||
The future in paediatric respirology | Q37735303 | ||
Prevalence of viral infection detected by PCR and RT-PCR in patients with acute exacerbation of COPD: a systematic review | Q37736623 | ||
Optimal airway antimicrobial therapy for cystic fibrosis: the role of inhaled aztreonam lysine | Q37738904 | ||
Creatine supplementation for patients with COPD receiving pulmonary rehabilitation: a systematic review and meta-analysis | Q37760275 | ||
Potential therapeutic targets for cardiac fibrosis: TGFbeta, angiotensin, endothelin, CCN2, and PDGF, partners in fibroblast activation | Q37764239 | ||
Heart failure and COPD: partners in crime? | Q37764936 | ||
Have advanced research technologies made real impact on respiratory medicine? | Q37774431 | ||
Prospects for an asthma vaccine | Q37776016 | ||
State of the art: how to set up a pulmonary rehabilitation program | Q37797560 | ||
Effects of aerobic training on psychosocial morbidity and symptoms in patients with asthma: a randomized clinical trial. | Q38374687 | ||
Population-based study of cystic fibrosis disease severity and haemochromatosis gene mutations. | Q39109346 | ||
Dermatophagoides pteronyssinus 2 regulates nerve growth factor release to induce airway inflammation via a reactive oxygen species-dependent pathway | Q39628891 | ||
Lipopolysaccharide induced connective tissue growth factor gene expression in human bronchial epithelial cells | Q39712347 | ||
Gender differences in asthma prevalence: variations with socioeconomic disadvantage | Q39904819 | ||
Smoke-free legislation and hospitalizations for childhood asthma | Q39950863 | ||
Genes that determine immunology and inflammation modify the basic defect of impaired ion conductance in cystic fibrosis epithelia | Q41212056 | ||
Cough challenge tests involving mechanical stimulation of the cervical trachea in patients with cough as a leading symptom | Q41985566 | ||
Reticular basement membrane fragmentation and potential epithelial mesenchymal transition is exaggerated in the airways of smokers with chronic obstructive pulmonary disease. | Q42474300 | ||
Iodine-123 metaiodobenzylguanidine scintigraphic assessment of pulmonary vascular status in patients with chronic obstructive pulmonary disease | Q42870585 | ||
High MW hyaluronan inhibits smoke inhalation-induced lung injury and improves survival. | Q42875334 | ||
The effect and mechanism of action of carbocysteine on airway bacterial load in rats chronically exposed to cigarette smoke | Q42921200 | ||
Controlled trial of cycled antibiotic prophylaxis to prevent initial Pseudomonas aeruginosa infection in children with cystic fibrosis | Q42930109 | ||
Lipoprotein patterns in adult cystic fibrosis: a cause for concern or marker for survival? | Q42960756 | ||
Risk of hepatitis B virus reactivation in patients with asthma or chronic obstructive pulmonary disease treated with corticosteroids | Q42970629 | ||
Clinical profile of adult cystic fibrosis patients with frequent epidemic clones of Pseudomonas aeruginosa. | Q43007664 | ||
Association between beta-adrenoceptor gene polymorphisms and relative response to beta 2-agonists and anticholinergic drugs in Japanese asthmatic patients | Q43025195 | ||
Metabolic abnormalities in adults with cystic fibrosis | Q43055623 | ||
Asthma and insulin resistance in children | Q43067653 | ||
The use of non-invasive ventilation for life-threatening asthma attacks: Changes in the need for intubation | Q43090429 | ||
Variability of sputum inflammatory cells in asthmatic patients receiving corticosteroid therapy: A prospective study using multiple samples | Q43099470 | ||
Exercise-induced wheeze: Fraction of exhaled nitric oxide-directed management. | Q43118743 | ||
Changes in the highest frequency of breath sounds without wheezing during methacholine inhalation challenge in children. | Q43138957 | ||
Azithromycin induces anti-viral responses in bronchial epithelial cells | Q43164854 | ||
Confirmation of asthma in an era of overdiagnosis | Q43194200 | ||
Differential expression of peroxisome proliferator activated receptor gamma and cyclin D1 does not affect proliferation of asthma- and non-asthma-derived airway smooth muscle cells | Q43195596 | ||
Treatment of early Pseudomonas aeruginosa infection in patients with cystic fibrosis: the ELITE trial | Q43227275 | ||
Nerve growth factor mediated SH2-Bbeta/Akt signal pathway activated in allergic airway challenge in mice | Q43233607 | ||
Aerosolized vancomycin for the treatment of MRSA after lung transplantation | Q43247008 | ||
Five-year outcome in COPD patients after their first episode of acute exacerbation treated with non-invasive ventilation | Q43749456 | ||
Different definitions in childhood asthma: how dependable is the dependent variable? | Q43932506 | ||
Effect of comorbid diabetes on length of stay and risk of death in patients admitted with acute exacerbations of COPD. | Q44015749 | ||
Relationship between exhaled nitric oxide and treatment response in COPD patients with exacerbations | Q44086453 | ||
Association between respiratory tract methicillin-resistant Staphylococcus aureus and survival in cystic fibrosis | Q44324883 | ||
Chronic obstructive pulmonary disease in the absence of chronic bronchitis in China | Q44364751 | ||
Gender differences in IgE-mediated allergic asthma in the epidemiology and natural history of asthma: Outcomes and Treatment Regimens (TENOR) study | Q44546127 | ||
Haemodynamic effects of proportional assist ventilation during high-intensity exercise in patients with chronic obstructive pulmonary disease. | Q44562463 | ||
Productive cough is an independent risk factor for the development of COPD in former smokers | Q45077297 | ||
Six-minute walk test in pulmonary rehabilitation: do all patients need a practice test? | Q45409397 | ||
P433 | issue | 3 | |
P921 | main subject | asthma | Q35869 |
cystic fibrosis | Q178194 | ||
P304 | page(s) | 540-552 | |
P577 | publication date | 2011-04-01 | |
P1433 | published in | Respirology | Q15753093 |
P1476 | title | Year-in-review 2010: asthma, COPD, cystic fibrosis and airway biology | |
P478 | volume | 16 |
Search more.